Evidence map›Paper›PMID 41603458›Full record

ArticleJournal of medicinal chemistry2026

Idler Compounds: A Simple Protocol for Openly Sharing Fridge Contents for Cross-Screening.

Rebecka Isaksson, Eve M Carter, Charlotte K Hind, J Mark Sutton, Hazel Rudgyard, Adam H Roberts, Christopher W Moon, Yinuo Wang, Todd Group Researchers, Sandra Codony and 3 more

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rebecka IsakssonSchool of Pharmacy and Structural Genomics Consortium, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.ORCID 0000-0002-6389-5046
Eve M CarterSchool of Pharmacy and Structural Genomics Consortium, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.ORCID 0000-0002-0896-6884
Charlotte K HindAntimicrobial Discovery, Development and Diagnostics, Countermeasures, Development, Evaluation and Preparedness, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, U.K.ORCID 0000-0002-3763-3106
J Mark SuttonAntimicrobial Discovery, Development and Diagnostics, Countermeasures, Development, Evaluation and Preparedness, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, U.K.
Hazel RudgyardDiscovery Group, Countermeasures, Development, Evaluation and Preparedness, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, U.K.
Adam H RobertsDiscovery Group, Countermeasures, Development, Evaluation and Preparedness, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, U.K.
Christopher W MoonDiscovery Group, Countermeasures, Development, Evaluation and Preparedness, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, U.K.
Yinuo WangSchool of Pharmacy and Structural Genomics Consortium, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.
Todd Group ResearchersSchool of Pharmacy and Structural Genomics Consortium, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.
Sandra CodonyInstitute of Biomedicine of the University of Barcelona (IBUB), Universitat de Barcelona, Barcelona 08028, Spain.
Antón L MartínezInnopharma Drug Screening Platform/Biofarma Research Group, CIMUS Research Center, Pharmacology Department, School of Pharmacy, University of Santiago de Compostela (USC) and Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela 15782, Spain.ORCID 0000-0002-1595-3459
Joanna BaconDiscovery Group, Countermeasures, Development, Evaluation and Preparedness, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, U.K.
Matthew H ToddSchool of Pharmacy and Structural Genomics Consortium, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.ORCID 0000-0001-7096-4751

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Academic drug discovery laboratories tend to accumulate collections of compounds with great potential value that merely reside in fridges and freezers. Cross screening these libraries against alternative targets holds significant potential for uncovering novel hits, but in the academic setting compound collections are rarely used, and shared, in this way. We present a short guide for collecting small molecules not being actively pursued in group projects (which we term "idlers") to establish an open compound library. We describe how a diverse subset of this library was screened against a panel of pathogens, with the resulting data made publicly available. We hope to encourage other academic groups to develop and share their own libraries of idlers, thereby maximizing the utility of existing resources, enabling new insights, and catalyzing novel research directions through open science.

Indexed as

Drug DiscoverySmall Molecule LibrariesDrug Evaluation, PreclinicalHumansSmall Molecule Libraries

Identifiers

PMID41603458
PMCPMC12928571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.